Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer (Q47419988)
Jump to navigation
Jump to search
scientific article published on 25 January 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer |
scientific article published on 25 January 2017 |
Statements
1 reference
Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer (English)
1 reference
Shawn Kothari
Charu Aggarwal
Joshua M Bauml
Evan W Alley
Tracey L Evans
John A Kosteva
Christine A Ciunci
Peter E Gabriel
Jeffrey C Thompson
Susan Stonehouse-Lee
Victoria E Sherry
Elizabeth Gilbert
Beth Eaby-Sandy
Faith Mutale
Gloria DiLullo
Roger B Cohen
Anil Vachani
25 January 2017
1 reference